Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.

Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK.

Cancer. 2004 Sep 1;101(5):1036-42.

2.

Cancer gene therapy utilizing interleukin-13 receptor alpha2 chain.

Kawakami K.

Curr Gene Ther. 2005 Apr;5(2):213-23. Review.

PMID:
15853729
3.

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.

Husain SR, Puri RK.

J Neurooncol. 2003 Oct;65(1):37-48. Review.

PMID:
14649884
4.

Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.

Joshi BH, Hogaboam C, Dover P, Husain SR, Puri RK.

Vitam Horm. 2006;74:479-504. Review.

PMID:
17027527
5.

Cytokine receptor as a sensitizer for targeted cancer therapy.

Kawakami K, Kawakami M, Puri RK.

Anticancer Drugs. 2002 Aug;13(7):693-9. Review.

PMID:
12187325
6.

Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.

Kioi M, Husain SR, Croteau D, Kunwar S, Puri RK.

Technol Cancer Res Treat. 2006 Jun;5(3):239-50. Review.

PMID:
16700620
7.

A review of studies on targeting interleukin 4 receptor for central nervous system malignancy.

Puri S, Puri S, Mahapatra AK, Hussain E, Sarkar C, Sinha S, Joshi BH.

Curr Mol Med. 2009 Aug;9(6):732-9. Review.

PMID:
19689300
8.

Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.

Kawakami M, Kawakami K, Puri RK.

J Neurooncol. 2003 Oct;65(1):15-25. Review.

PMID:
14649882
9.

An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link.

Debinski W.

Crit Rev Oncog. 1998;9(3-4):255-68. Review.

PMID:
10201630
10.

Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy.

Kawakami K, Kawakami M, Puri RK.

Crit Rev Immunol. 2001;21(1-3):299-310. Review.

PMID:
11642612
11.

Histology and molecular pathology of pediatric brain tumors.

Pfister S, Hartmann C, Korshunov A.

J Child Neurol. 2009 Nov;24(11):1375-86. doi: 10.1177/0883073809339213. Review.

PMID:
19841426
12.

Cintredekin besudotox in treatment of malignant glioma.

Mut M, Sherman JH, Shaffrey ME, Schiff D.

Expert Opin Biol Ther. 2008 Jun;8(6):805-12. doi: 10.1517/14712598.8.6.805 . Review.

PMID:
18476792
13.

Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease.

Mentink-Kane MM, Wynn TA.

Immunol Rev. 2004 Dec;202:191-202. Review.

PMID:
15546394
14.

Targeted toxin therapy for malignant astrocytoma.

Hall WA.

Neurosurgery. 2000 Mar;46(3):544-51; discussion 552. Review.

PMID:
10719849
15.

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.

Shimamura T, Husain SR, Puri RK.

Neurosurg Focus. 2006 Apr 15;20(4):E11. Review.

PMID:
16709016
16.

Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis.

Jakubzick C, Kunkel SL, Puri RK, Hogaboam CM.

Immunol Res. 2004;30(3):339-49. Review.

PMID:
15531774
17.

Cytoplasmic tail of IL-13Ralpha2 regulates IL-4 signal transduction.

Andrews AL, Nordgren IK, Kirby I, Holloway JW, Holgate ST, Davies DE, Tavassoli A.

Biochem Soc Trans. 2009 Aug;37(Pt 4):873-6. doi: 10.1042/BST0370873. Review.

PMID:
19614610
18.

Recombinant cytotoxins specific for cancer cells.

Debinski W.

Ann N Y Acad Sci. 1999;886:297-9. Review. No abstract available.

PMID:
10667244
19.

[Progress of molecular pathology in pediatric brain tumor].

WANG YJ, PIAO YS, LU DH.

Zhonghua Bing Li Xue Za Zhi. 2011 Mar;40(3):206-8. Review. Chinese. No abstract available.

PMID:
21575401
20.

[Present status of the problem of the structure and chemism of experimental brain neoplasms].

Avtsyn AP, Abdullakhodzhaeva MS.

Usp Sovrem Biol. 1970 Nov-Dec;70(3):430-42. Review. Russian. No abstract available.

PMID:
4324487

Supplemental Content

Support Center